NanoString Technologies Financials

NanoString Technologies Stock Summary

NanoString Technologies competes with Veracyte, Syros Pharmaceuticals, Seres Therapeutics, Iovance Biotherapeutics, and 10X Genomics. NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. Nanostring Tech operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 766 people.

NanoString Technologies Key Financial Ratios

NanoString Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NanoString Technologies's current stock value. Our valuation model uses many indicators to compare NanoString Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NanoString Technologies competition to find correlations between indicators driving NanoString Technologies's intrinsic value. More Info.NanoString Technologies is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value NanoString Technologies by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

NanoString Technologies Market Pulse

Along with financial statement analysis, the daily predictive indicators of NanoString Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NanoString Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of NanoString Technologies based on widely used predictive technical indicators. In general, we focus on analyzing NanoString Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NanoString Technologies's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

If you are still planning to invest in NanoString Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NanoString Technologies' history and understand the potential risks before investing.